Investigator Initiated Clinical Trials
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Overview
Cancer League of Colorado offers support for investigator-initiated clinical trials, though detailed program information was not available in the provided website content. This appears to be a distinct funding category beyond their Research and Service Grants programs.
What Cancer League of Colorado Inc actually gave
Source: IRS Form 990, 2025
- Grants in 2025
- 25
- Total given
- $1.29M
- Median grant
- $10K
- Range
- $7,500–$960K
- By dollars: Colorado >99%, Montana <1%. Top recipient cities: Denver, CO; Aurora, CO; Boulder, CO.
- 0% of grants with a stated purpose were for general or operating support.
- 28% of recipients were new grantees, not repeat recipients.
Example grants
University of Colorado Denver · Denver, CO
Cancer Research/Clinical Trials
$960K
National Jewish Center Inst · Denver, CO
Cancer Research
$60K
The Regents of the Univ of CO · Denver, CO
Cancer Research
$30K
Univ of Co - Boulder · Boulder, CO
Cancer Research
$30K
Co State University · Fort Collins, CO
Cancer Research
$30K
Focus Areas & Funding Uses
Fields of Work
- Cancer
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Institutes of Health
Amount
$50K – $600K
Deadline
October 19, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $350,000
Deadline
November 6, 2026
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $300,000
Deadline
November 10, 2026
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $150,000
Deadline
November 10, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
National Institutes of Health
Amount
Up to $200,000
Deadline
November 17, 2026
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
National Institutes of Health
Amount
Up to $499,999
Deadline
January 7, 2027
Ready to apply for Investigator Initiated Clinical Trials?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Investigator Initiated Clinical Trials. Now let's win it.